Shalby Limited Issues USD 13.27 Million Standby Letter of Credit Under SEBI Regulation 30
Shalby Limited has issued a standby letter of credit worth up to USD 13.27 million through IndusInd Bank Limited for its overseas step-down subsidiary Shalby Advanced Technologies, Inc., USA. The transaction was disclosed under SEBI Regulation 30 compliance framework, with the company confirming no material financial or operational impact is expected. This arrangement is designed to help the subsidiary obtain credit facilities while maintaining regulatory transparency and supporting the company's international healthcare technology operations.

*this image is generated using AI for illustrative purposes only.
Shalby Limited has announced the issuance of a standby letter of credit worth up to USD 13.27 million through IndusInd Bank Limited. This financial instrument has been arranged specifically for Shalby Advanced Technologies, Inc., USA, which is the company's overseas step-down subsidiary focused on advanced medical technologies. The disclosure was made under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
Transaction Details
The standby letter of credit arrangement involves comprehensive regulatory compliance and operational parameters:
| Parameter: | Details |
|---|---|
| Credit Amount: | Up to USD 13.27 million |
| Issuing Bank: | IndusInd Bank Limited |
| Beneficiary: | Shalby Advanced Technologies, Inc., USA |
| Regulatory Framework: | SEBI Regulation 30 compliance |
| Transaction Nature: | Step-down subsidiary support |
Regulatory Compliance Framework
The company has fulfilled its disclosure obligations under SEBI Listing Regulations, providing detailed information as required under SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123. The transaction involves no promoter or promoter group interest, except for the step-down subsidiary being the beneficiary. This arrangement is structured to help the subsidiary obtain credit facilities while maintaining arm's length transaction principles.
Financial Impact Assessment
Shalby Limited has specifically stated that providing this standby letter of credit is in the overall interest of the company, as it will help the step-down subsidiary in obtaining credit facilities. The management has confirmed that no material financial or operational impact is foreseen from this arrangement, suggesting it serves as operational support rather than a significant capital commitment.
Strategic Implications
The issuance demonstrates Shalby's commitment to supporting its international subsidiary operations within a structured regulatory framework. This financial backing ensures adequate liquidity support for Shalby Advanced Technologies, Inc.'s operational requirements while maintaining transparency through proper regulatory disclosures. The arrangement reflects the company's strategy to strengthen its global healthcare technology operations while adhering to compliance requirements.
Historical Stock Returns for Shalby
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.01% | +4.89% | +10.86% | -34.79% | -17.11% | +38.59% |
What specific expansion plans does Shalby Advanced Technologies have in the US market that would require this credit facility backing?
How might this financial arrangement impact Shalby's ability to pursue other international acquisitions or partnerships in the medical technology sector?
Will Shalby need to establish similar credit facilities for other overseas subsidiaries as part of its global expansion strategy?


































